V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220019979 | 220009649 | null | 76.1 | null | 2015-06-19 | 2015-09-30 | MITOXANTRONE + TRETINOIN | N | N | 220036654 | INTERFERON |
| 220019981 | 220009656 | 1.68 | 82 | Curative (C) | 2018-02-15 | 2018-02-15 | Cetuximab 7 day (>Cycle 2) | 02 | N | 220036675 | MERCAPTOPURINE |
| 220019982 | 220009659 | 1.76 | 76 | Palliative (P) | 2018-06-21 | 2018-06-22 | Cisplatin +Fluorouracil (3 wk) | null | null | 220036683 | BORTEZOMIB |
| 220019983 | 220009668 | 1.53 | 60 | Curative (C) | 2015-08-29 | 2015-09-05 | CYCLOPHOSPHAMIDE + FLUDARABINE + THIOTEPA | N | N | 220036733 | FIGARO TRIAL |
| 220019984 | 220009669 | 1.49 | 67 | Curative (C) | 2014-01-24 | 2014-01-24 | ALL UKALL2003 TRIAL | N | N | 220036735 | ARSENIC TRIOXIDE + ATRA |
| 220019985 | 220009674 | 1.7 | 80.3 | null | 2018-09-15 | 2018-10-14 | QUASAR 2 TRIAL | N | N | 220036750 | ATG + BUSULFAN + FLUDARABINE + THIOTEPA |
| 220019986 | 220009677 | 1.53 | 83 | Neo-adjuvant (N) | 2018-08-12 | 2018-11-04 | EOX | N | N | 220036760 | TRASTUZUMAB EMTANSINE |
| 220019987 | 220009680 | null | null | Palliative (P) | 2013-08-15 | 2013-08-15 | NHL 2003 Gp B COP | N | N | 220000653 | MITOXANTRONE + TRETINOIN |
| 220019988 | 220009683 | 1.65 | 79 | Palliative (P) | 2016-03-01 | 2016-04-17 | Cisplatin + Docetaxel +Fluorouracil | N | N | 220002814 | EOX |
| 220019989 | 220009688 | 1.74 | 72.5 | Curative (C) | 2015-10-14 | 2016-10-23 | ATG + Busulfan + Fludarabine + Thiotepa | 2 | N | 220003896 | PEMBROLIZUMAB |
| 220019990 | 220015113 | 1.58 | 91.5 | Palliative (P) | 2017-01-05 | 2017-04-25 | Alemtuzumab + Cyclophos TBI Allo | N | Y | 220004682 | ATG + BUSULFAN + FLUDARABINE + THIOTEPA |
| 220019991 | 220009700 | 1.36 | null | Palliative (P) | 2018-10-14 | 2018-11-02 | PEMBROLIZUMAB | null | N | 220014128 | SPANISH MAINTENANCE |
| 220019992 | 220018243 | null | 114 | Palliative (P) | 2018-05-22 | 2018-05-27 | Alemtuz+Cyclophos+Fludara Allo | 2 | N | 220016525 | BUSULPHAN |
| 220019993 | 220009710 | null | null | Palliative (P) | 2013-12-14 | 2014-03-31 | IGEV R | null | null | 220017673 | ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE |
| 220019994 | 220015126 | null | null | null | 2018-04-05 | 2018-04-21 | CYTARABINE + FLUDARABINE + IDARUBICIN | null | N | 220018242 | DHAP |
| 220019995 | 220009725 | 1.24 | null | Palliative (P) | 2014-02-01 | 2014-02-01 | CVAD | N | N | 220020796 | CISPLATIN + FLUOROURACIL |
| 220019996 | 220009730 | 1.67 | 70 | Palliative (P) | 2015-02-20 | 2015-03-30 | DABRAFENIB + TRAMETINIB | 02 | N | 220021070 | DABRAFENIB + TRAMETINIB |
| 220019997 | 220009734 | 1.83 | 76.6 | null | 2014-11-23 | 2015-05-11 | Cytarabine+Methotrexate Intrathecal | null | null | 220021758 | ALEMTUZUMAB + CYCLOPHOSPHAMIDE |
| 220019998 | 220015133 | 1.57 | 71.1 | Curative (C) | 2017-12-28 | 2018-01-05 | Mercaptopurine | N | N | 220021916 | CHOP R |
| 220019999 | 220015133 | 1.67 | 73 | Disease modification (D) | 2018-09-17 | 2019-07-14 | Arsenic Triox + Tretinoin Ind W1-4 | 02 | N | 220021916 | CAMELLIA TRIAL |
| 220020000 | 220009741 | 1.73 | 17.1 | null | 2015-01-05 | 2015-04-25 | AML Relapsed FLA | 02 | N | 220022309 | CARBOPLATIN + IRINOTECAN |
| 220020001 | 220021034 | null | null | Palliative (P) | 2015-02-23 | 2015-03-02 | Cytarabine+Methotrexate Intrathecal | N | N | 220022881 | METHOTREXATE + PEGASPARGASE |
| 220020002 | 220009748 | 1.79 | 91.4 | Disease modification (D) | 2017-08-31 | 2017-10-23 | CYTARABINE + MITOXANTRONE | N | N | 220023457 | MA |
| 220020003 | 220018253 | 1.75 | 84.5 | Palliative (P) | 2017-08-16 | 2018-04-10 | FIGARO TRIAL | N | N | 220027021 | ETOPOSIDE |
| 220020004 | 220015142 | null | 67 | Palliative (P) | 2018-09-22 | 2018-09-25 | Alemtuzumab + Cyclophos TBI Allo | null | N | 220027990 | CYTARABINE IT + METHOTREXATE |
| 220020005 | 220020013 | 1.82 | 0 | Palliative (P) | 2017-04-06 | 2017-07-05 | VINORELBINE | 02 | N | 220028838 | VINORELBINE |
| 220020006 | 220009774 | null | 85.7 | Curative (C) | 2019-05-16 | 2019-05-24 | PAC-E | N | N | 220029686 | ETOPOSIDE |
| 220020007 | 220021037 | 1.77 | 86 | Palliative (P) | 2017-05-15 | 2017-11-01 | MidAC | N | N | 220031271 | CYTARABINE + IDARUBICIN |
| 220020008 | 220009783 | null | null | null | 2017-10-20 | 2017-10-24 | CLADRIBINE + CYTARABINE + DAUNORUBICIN | 99 | null | 220032124 | ARSENIC TRIOXIDE |
| 220020009 | 220009784 | 1.57 | 76.1 | Not known (9) | 2018-06-03 | 2018-08-24 | Sorafenib | 02 | N | 220032395 | CAPECITABINE |
| 220020010 | 220018262 | null | 16 | Palliative (P) | 2015-09-30 | 2015-10-28 | Arsenic Triox + Tretinoin Ind W1-4 | 01 | N | 220033588 | TRASTUZUMAB |
| 220020011 | 220009790 | 1.65 | 86.9 | Curative (C) | 2017-04-21 | 2017-05-04 | MACE | N | N | 220033707 | VINORELBINE |
| 220020012 | 220009792 | 1.77 | 94.8 | Palliative (P) | 2018-08-26 | 2018-08-26 | IPILIMUMAB + NIVOLUMAB | 02 | null | 220034024 | PEMETREXED |
| 220020013 | 220009794 | 1.69 | 80 | Curative (C) | null | 2014-01-16 | FIGARO TRIAL | N | N | 220034048 | BUSULPHAN + CYCLO |
| 220020014 | 220015162 | 1.7 | 101.699 | null | 2019-04-18 | 2019-07-03 | FIGARO TRIAL | N | null | 220034188 | NHL 2003 |
| 220020015 | 220009801 | 1.61 | null | Curative (C) | 2018-08-04 | 2018-08-18 | CYTARABINE + Vosaroxin | 01 | N | 220034318 | TRASTUZUMAB |
| 220020016 | 220009804 | 1.73 | 81.2 | Disease modification (D) | null | 2014-11-25 | AML LI-1 Trial | 01 | N | 220034508 | CISPLATIN + FLUOROURACIL |
| 220020017 | 220009813 | 1.83 | 73.6 | Curative (C) | 2017-07-04 | 2017-07-11 | INTERFERON | N | N | 220035216 | INTERFERON |
| 220020018 | 220009820 | null | 77.1 | null | 2013-08-26 | 2013-09-27 | ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN | null | null | 220035628 | VINCRISTINE |
| 220020019 | 220009822 | 1.65 | 58.8 | Palliative (P) | 2015-03-05 | 2015-03-05 | GCLAC | N | N | 220020987 | FIGARO TRIAL |
| 220020020 | 220009825 | 1.6 | 74.6 | Curative (C) | 2019-09-01 | 2019-09-05 | LIPOSOMAL CYTARABINE | N | null | 220024970 | ALEMTUZUMAB + CYCLOPHOSPHAMIDE |
| 220020021 | 220021040 | 1.8 | 64.7 | Palliative (P) | 2018-10-27 | 2019-03-02 | Cisplatin 7 day | N | Y | 220026545 | VINORELBINE |
| 220020022 | 220004055 | 1.69 | 0 | Curative (C) | 2015-04-04 | 2015-04-04 | IMATINIB | 02 | N | 220000145 | IMATINIB |
| 220020023 | 220004060 | 1.62 | 0 | Disease modification (D) | 2016-02-21 | 2016-10-12 | Imatinib 400mg | N | N | 220000223 | IMATINIB |
| 220020025 | 220004067 | 1.75 | 0 | Curative (C) | null | 2018-04-21 | Imatinib 400mg | 2 | N | 220000374 | IMATINIB |
| 220020026 | 220004069 | null | null | Disease modification (D) | 2017-05-01 | 2017-05-01 | IMATINIB | N | N | 220000450 | IMATINIB |
| 220020027 | 220004077 | 0 | 100 | Palliative (P) | 2016-05-04 | 2016-05-05 | Imatinib 400mg | N | N | 220000633 | IMATINIB |
| 220020028 | 220012157 | null | null | null | 2018-03-14 | 2018-10-09 | IMATINIB | 2 | N | 220000723 | IMATINIB |
| 220020029 | 220004084 | 1.62 | 70 | Curative (C) | 2017-05-18 | 2017-06-18 | IMATINIB | N | N | 220000807 | IMATINIB |
| 220020030 | 220004087 | null | 83.5 | Disease modification (D) | 2017-08-12 | 2017-08-12 | IMATINIB | N | N | 220001016 | IMATINIB |